Avanzanite Bioscience B.V. (Avanzanite), a rapidly growing commercial-stage European specialty pharmaceutical company focused ...

The first IDEAL Japan agreement was signed with the National Cancer Center Japan. Through this first project that has just entered the program, Debiopharm will fund discovery research targeting colon ...

European Commission (EC) has granted marketing authorization for Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab. Approved in 100 mg and 350 mg ...

Founded in 2008, Cinemo provides world-leading digital media solutions for the highly demanding automotive market. Trusted by more than 40 market-leading OEMs and over 20 tier-1 suppliers, Cinemo has ...